Marketa Koberska

Marketa Koberska

Auto-generated profile, based on publicly available information

Marketa Koberska

Institute of Microbiology of the CAS

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2024 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
RDRahul Deb
Rahul Deb
MTMarcelo D. T. Torres
Marcelo D. T. Torres
MBMiroslav Boudný
Miroslav Boudný
MKMarkéta Koběrská
Markéta Koběrská
FCFloriana Cappiello
Floriana Cappiello
RVRobert Vácha
Robert Vácha
Peptides that form transmembrane barrel-stave pores are potential alternative therapeutics for bacterial infections and cancer. However, their optimization for clinical translation is hampered by a lack of sequence-function understanding. Recently, we have de novo designed the first synthetic barrel-stave pore-forming antimicrobial peptide with an identified function of all residues. Here, we systematically mutate the peptide to improve pore-forming ability in anticipation of enhanced activity. Using computer simulations, supported by liposome leakage and atomic force microscopy experiments, we find that pore-forming ability, while critical, is not the limiting factor for improving activity in the submicromolar range. Affinity for bacterial and cancer cell membranes needs to be optimized simultaneously. Optimized peptides more effectively killed antibiotic-resistant ESKAPEE bacteria at submicromolar concentrations, showing low cytotoxicity to human cells and skin model. Peptides showed systemic anti-infective activity in a preclinical mouse model of Acinetobacter baumannii infection. We also demonstrate peptide optimization for pH-dependent antimicrobial and anticancer activity.

6 December 2024 in Nature Chemistry
Verified
Journal Article
Open access
PDF file
TMTakahiro Mori
Takahiro Mori
YMYoshitaka Moriwaki
Yoshitaka Moriwaki
KSKosuke Sakurada
Kosuke Sakurada
SLShuang Lyu
Shuang Lyu
SKStanislav Kadlcik
Stanislav Kadlcik
IAIkuro Abe
Ikuro Abe
The biosynthesis of the lincosamide antibiotics lincomycin A and celesticetin involves the pyridoxal-5′-phosphate (PLP)-dependent enzymes LmbF and CcbF, which are responsible for bifurcation of the biosynthetic pathways. Despite recognizing the same S-glycosyl-l-cysteine structure of the substrates, LmbF catalyses thiol formation through β-elimination, whereas CcbF produces S-acetaldehyde through decarboxylation-coupled oxidative deamination. The structural basis for the diversification mechanism remains largely unexplored. Here we conduct structure–function analyses of LmbF and CcbF. X-ray crystal structures, docking and molecular dynamics simulations reveal that active-site aromatic residues play important roles in controlling the substrate binding mode and the reaction outcome. Furthermore, the reaction selectivity and oxygen-utilization of LmbF and CcbF were rationally engineered through structure- and calculation-based mutagenesis. Thus, the catalytic function of CcbF was switched to that of LmbF, and, remarkably, both LmbF and CcbF variants gained the oxidative-amidation activity to produce an unnatural S-acetamide derivative of lincosamide.

18 September 2025 in bioRxiv
Verified
Preprint
Open access
OHOndrej Hrebicek
Ondrej Hrebicek
SKStanislav Kadlcik
Stanislav Kadlcik
LNLucie Najmanova
Lucie Najmanova
JJJiri Janata
Jiri Janata
JKJana Kamanova
Jana Kamanova
ZKZdenek Kamenik
Zdenek Kamenik
Gene clusters are key structural and functional units that encode diverse phenotypes in genomes, from metabolism to pathogenesis. As genome sequencing expands, tools for systematic exploration of this growing data are increasingly needed. We present CluSeek, an open-source, Python-based platform for discovering, visualizing, and analyzing gene clusters across all GenBank data. Unlike existing tools, CluSeek does not rely on predefined cluster types or reference libraries but enables mining of any gene neighborhoods containing colocalized homologs of user-specified genes. It features an intuitive graphical interface suitable for non-bioinformaticians and is freely available at https://cluseek.com . We demonstrate the versatility of Cluseek in two distinct case studies: (i) mining of specialized metabolites, where CluSeek uncovered over 16 new classes containing the bioactivity-enhancing 4-alkyl-L-proline moiety, previously known in only three Golden Era antibiotic classes; and (ii) analysis of type III secretion systems present in Bordetella species, revealing previously unrecognized taxonomic distribution, and genetic variants, including gene multiplications and novel components with potential functional significance. Abstract Figure:

12 August 2025 in mBio
Verified
Journal Article
Open access
MKMarkéta Koběrská
Markéta Koběrská
LVLudmila Veselá
Ludmila Veselá
MNMichaela Novotná
Michaela Novotná
DMDurga Mahor
Durga Mahor
AMAninda Mazumdar
Aninda Mazumdar
GNGabriela Balikova Novotna
Gabriela Balikova Novotna
ABCF-ATPases are increasingly recognized as translation factors that rescue stalled ribosomes when they encounter difficult mRNA templates or are stalled by antibiotics. The latter defines antibiotic resistance ABCF (ARE ABCF) proteins, known for their role in antibiotic resistance. However, in this study, we reveal a broader role of ARE ABCFs in antibiotic-responsive regulation. Using genetic, OMICs, and biochemical approaches, we showed that ARE ABCF proteins TiaA and Are5sc in Streptomyces coelicolor use their resistance functions to modulate specialized metabolism and proteosynthesis in response to lincosamide, streptogramin A, and pleuromutilin (LS A P) antibiotics. Although under LS A P exposure, either Are5sc or TiaA is essential for activating the biosynthesis of the redox-active antimicrobial actinorhodin, these proteins exhibit distinct functions at the proteome level, defined by their resistance profiles and temporally regulated expression. Are5sc facilitates early adaptive responses by modulating the WblC regulon across a broad range of LS A P concentrations, while TiaA is induced later, specifically at higher concentrations, where it suppresses antibiotic stress responses, particularly against pleuromutilins. TiaA function thus reflects the ecological context of LS A P antibiotics as pleuromutilins are produced by fungi, whereas lincosamides/streptogramins originate from actinomycetes. Our findings demonstrate that ARE ABCF proteins, through their resistance function, act as global regulators of translation, mirroring the roles of non-ARE ABCF proteins like EttA. This highlights their broader ecological and physiological significance, extending beyond their established role in antibiotic resistance. IMPORTANCE: Bacteria adapt to diverse stimuli mainly through transcriptional changes that regulate adaptive protein factors. Here, we show that responses to protein synthesis-inhibiting antibiotics are fine-tuned by antibiotic resistance ABCF proteins at the translational level, enabling bacteria to differentiate between antibiotic classes and concentrations for a tailored response. Additionally, we have demonstrated that these proteins can specialize in conferring high-level resistance to specific antibiotics. Given their prevalence in pathogenic bacteria, antibiotic resistance ABCF (ARE ABCF) proteins may play a crucial role in resistance development, particularly against new antibiotics targeting the ribosomal catalytic center, presenting a significant challenge for antimicrobial therapy.

25 February 2026 in Research Square
Verified
Preprint
Open access
PDF file
GNGabriela Balikova Novotna
Gabriela Balikova Novotna
MNMichaela Novotná
Michaela Novotná
PSPetr Slavík
Petr Slavík
FDFanny Demay
Fanny Demay
DMDurga Mahor
Durga Mahor
CIC. Innis
C. Innis
Lincosamides are an important class of clinically used antibiotics that inhibit translation by binding to the peptidyl transferase center of the ribosome. However, their efficacy is impaired by the widespread acquisition of genes coding for erythromycin resistance methyltransferase (Erm), which confer resistance by dimethylating adenine A2058 in the 23S ribosomal RNA. Here, we report clincelin, a novel chimeric lincosamide that retains conserved lincosamide thiooctose core and integrates structural features from two natural antibiotics—a propylated proline from lincomycin and salicylate from celesticetin—together with additional clinically validated C7 chlorination. Biochemical and cellular analyses revealed that the presence of salicylate and chlorination synergistically enhances intracellular accumulation, giving clincelin greater antibacterial activity than the parent compounds and the clinically used clindamycin. Notably, clincelin partially retains its efficacy against erm -mediated resistant pathogens, which is explained by cryo-electron microscopy showing that the salicylate moiety adopts distinct binding modes on drug-sensitive versus A2058-dimethylated Staphylococcus aureus ribosomes. Altogether, a comprehensive functional understanding of lincosamide structural modifications will enable the development of novel agents designed to overcome existing resistance.

16 December 2020 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
VVVladimir Vimberg
Vladimir Vimberg
JCJorunn Pauline Cavanagh
Jorunn Pauline Cavanagh
MNMichaela Novotna
Michaela Novotna
JLJakub Lenart
Jakub Lenart
BNBich Nguyen Thi Ngoc
Bich Nguyen Thi Ngoc
GNGabriela Balikova Novotna
Gabriela Balikova Novotna